Head-To-Head Review: Firefly Neuroscience (NASDAQ:AIFF) & OneMedNet (NASDAQ:ONMD)

Firefly Neuroscience (NASDAQ:AIFF) and OneMedNet (NASDAQ:ONMD) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, dividends, risk and earnings.

Earnings & Valuation

This table compares Firefly Neuroscience and OneMedNet”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Firefly Neuroscience	$1.14 million	14.73	-$19.88 million	($0.59)	-1.81
OneMedNet	$1.36 million	28.45	-$2.80 million	($0.16)	-4.08

OneMedNet has higher revenue and earnings than Firefly Neuroscience. OneMedNet is trading at a lower price-to-earnings ratio than Firefly Neuroscience, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Firefly Neuroscience and OneMedNet’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Firefly Neuroscience	-506.23%	-90.17%	-72.05%
OneMedNet	-584.20%	N/A	-521.20%

Insider and Institutional Ownership

5.0% of Firefly Neuroscience shares are owned by institutional investors. Comparatively, 0.9% of OneMedNet shares are owned by institutional investors. 6.9% of Firefly Neuroscience shares are owned by insiders. Comparatively, 50.2% of OneMedNet shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Risk & Volatility

Firefly Neuroscience has a beta of 0.55, meaning that its share price is 45% less volatile than the S&P 500. Comparatively, OneMedNet has a beta of 1.12, meaning that its share price is 12% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current recommendations for Firefly Neuroscience and OneMedNet, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Firefly Neuroscience	1	0	0	0	1.00
OneMedNet	1	0	0	0	1.00

Summary

OneMedNet beats Firefly Neuroscience on 7 of the 11 factors compared between the two stocks.

About Firefly Neuroscience

Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.

About OneMedNet

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.